GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Fu - Proj 3

$276,966
Feng Fu · Dartmouth College · P20 · FY2020 · GM

Prevention of Prostate Cancer by Sulforaphane

$276,934
Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA

Project 5: Microenvironment manipulation using anti-angiogenics to improve immunotherapy in melanoma

$276,920
Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA

Prostate Cancer Prevention by Diallyl Trisulfide

$276,772
Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA

Prostate Cancer Prevention by Diallyl Trisulfide

$276,733
Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · CA

Prostate Cancer Prevention by Diallyl Trisulfide

$276,692
Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA

Aurora-A/BTAK/STK15 Oncoprotein in Mitotic Spindle Assembly and Checkpoint Respon

$276,633
Subrata Sen · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA

Overcoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell Biotherapeutic

$276,544
Edgardo Rodriguez · Ioncologi Inc · R42 · FY2025 · CA

Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer

$276,443
King Kwong · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Molecular Pharmacology & Biochemistry of Dual Specificity Phosphatase Inhibitors

$276,044
John S Lazo · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA

Preclinical development and clinical monitoring of adoptive immune therapy

$275,946
Jeremy Rose · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

Project 3: Improving therapeutic approaches for breast cancer brain metastases

$275,841
Nancy U Lin · Dana-Farber Cancer Inst · P50 · FY2019 · CA

Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer

$275,841
Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2019 · CA

Local nano-immune modulation for the systemic treatment of lymphoma

$275,837
Adam Yuh Lin · Northwestern University At Chicago · K08 · FY2025 · CA

Local nano-immune modulation for the systemic treatment of lymphoma

$275,837
Adam Yuh Lin · Northwestern University At Chicago · K08 · FY2024 · CA

BUB1 in Chromosomal Instability and Tumorigenesis

$275,455
Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2013 · CA

Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents

$275,345
Christine Elizabeth Canman · University Of Michigan At Ann Arbor · R01 · FY2012 · CA

Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents

$275,345
Christine Elizabeth Canman · University Of Michigan At Ann Arbor · R01 · FY2011 · CA

Oncolytic Adenoviruses for Glioma Therapy

$275,178
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA

DNA damage signaling in oxygen toxicity in lung cells

$275,000
University Of Texas Hlth Ctr At Tyler · R01 · FY2004 · HL

SBIR Phase I: Engineering drugs that sense and respond to disease

$275,000
Elliot P Tague · Synsorybio, Inc. · · FY2024 · TIP

Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers

$274,871
Wei R. Chen · University Of Central Oklahoma · R01 · FY2017 · CA

Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression

$274,871
Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Flow Cytometry Shared Resource (FCSR)

$274,603
Zoran Galic · University Of California Los Angeles · P30 · FY2024 · CA

Flow Cytometry Shared Resource (FCSR)

$274,597
Zoran Galic · University Of California Los Angeles · P30 · FY2023 · CA